COVID-19 Impact on Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-over-counter-otc-drugs-dietary-supplements-market-insights-forecast-to-2026_en.gif)
Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into
The Over the Counter (OTC) Drugs & Dietary Supplements market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over the Counter (OTC) Drugs & Dietary Supplements market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over the Counter (OTC) Drugs & Dietary Supplements Market Share Analysis
Over the Counter (OTC) Drugs & Dietary Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over the Counter (OTC) Drugs & Dietary Supplements business, the date to enter into the Over the Counter (OTC) Drugs & Dietary Supplements market, Over the Counter (OTC) Drugs & Dietary Supplements product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into
- Analgesic & pain relievers
- Dermatological products
- Cough, cold, and flu products
- Vitamin supplements
- Mineral Supplements
- Ophthalmic Products
- Pharmacies
- Grocery Stores
- Vitamin
- Health Food Stores
- Online Pharmacies
The Over the Counter (OTC) Drugs & Dietary Supplements market is analysed and market size information is provided by regions (countries).
The key regions covered in the Over the Counter (OTC) Drugs & Dietary Supplements market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over the Counter (OTC) Drugs & Dietary Supplements Market Share Analysis
Over the Counter (OTC) Drugs & Dietary Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over the Counter (OTC) Drugs & Dietary Supplements business, the date to enter into the Over the Counter (OTC) Drugs & Dietary Supplements market, Over the Counter (OTC) Drugs & Dietary Supplements product introduction, recent developments, etc.
The major vendors covered:
- Pfizer Inc.
- Novartis International AG
- Roche Holding AG
- Merck & Co., Inc.
- Sanofi S.A
- Johnson & Johnson
- Gilead Sciences
- GlaxoSmithKline plc.
- Bayer Healthcare AG
- AstraZeneca plc.
- Alacer Corp.
- Alcon Inc.
- Alfresa Pharma Corporation
- Alkalon A/S
- Alliance Healthcare
- Allergan, Plc.
- Reckitt Benckiser Plc.
- Bausch & Lomb
- AbbVie Inc.
- The Colgate-Palmolive Company
1 STUDY COVERAGE
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
1.2 Market Segments
1.3 Key Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type
1.4.2 Analgesic & pain relievers
1.4.3 Dermatological products
1.4.4 Cough, cold, and flu products
1.4.5 Vitamin supplements
1.4.6 Mineral Supplements
1.4.7 Ophthalmic Products
1.5 Market by Application
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application
1.5.2 Pharmacies
1.5.3 Grocery Stores
1.5.4 Vitamin
1.5.5 Health Food Stores
1.5.6 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Over the Counter (OTC) Drugs & Dietary Supplements Industry Impact
1.6.1 How the Covid-19 is Affecting the Over the Counter (OTC) Drugs & Dietary Supplements Industry
1.6.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Over the Counter (OTC) Drugs & Dietary Supplements Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Over the Counter (OTC) Drugs & Dietary Supplements Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Estimates and Forecasts
2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2015-2026
2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026
2.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2020 Versus 2026
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
3.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020)
3.1.2 Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers (2015-2020)
3.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers
3.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020)
3.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
3.2.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
3.4 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Base Distribution, Product Types
3.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
3.4.3 Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2015-2020)
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020)
4.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Type (2021-2026)
4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2015-2020)
5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020)
5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020)
5.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Application (2021-2026)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements by Country
6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
7 EUROPE
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements by Country
7.1.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
7.1.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements by Region
8.1.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region
8.1.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
8.3 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements by Country
9.1.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
9.1.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
9.3 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements by Country
10.1.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
10.1.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
10.3 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Corporation Information
11.2.2 Novartis International AG Description, Business Overview and Total Revenue
11.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.2.5 Novartis International AG Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Corporation Information
11.3.2 Roche Holding AG Description, Business Overview and Total Revenue
11.3.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.3.5 Roche Holding AG Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Corporation Information
11.4.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi S.A
11.5.1 Sanofi S.A Corporation Information
11.5.2 Sanofi S.A Description, Business Overview and Total Revenue
11.5.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.5.5 Sanofi S.A Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Corporation Information
11.7.2 Gilead Sciences Description, Business Overview and Total Revenue
11.7.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.7.5 Gilead Sciences Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Corporation Information
11.8.2 GlaxoSmithKline plc. Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Corporation Information
11.9.2 Bayer Healthcare AG Description, Business Overview and Total Revenue
11.9.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.9.5 Bayer Healthcare AG Recent Development
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Corporation Information
11.10.2 AstraZeneca plc. Description, Business Overview and Total Revenue
11.10.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.10.5 AstraZeneca plc. Recent Development
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.1.5 Pfizer Inc. Recent Development
11.12 Alcon Inc.
11.12.1 Alcon Inc. Corporation Information
11.12.2 Alcon Inc. Description, Business Overview and Total Revenue
11.12.3 Alcon Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Alcon Inc. Products Offered
11.12.5 Alcon Inc. Recent Development
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Corporation Information
11.13.2 Alfresa Pharma Corporation Description, Business Overview and Total Revenue
11.13.3 Alfresa Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Alfresa Pharma Corporation Products Offered
11.13.5 Alfresa Pharma Corporation Recent Development
11.14 Alkalon A/S
11.14.1 Alkalon A/S Corporation Information
11.14.2 Alkalon A/S Description, Business Overview and Total Revenue
11.14.3 Alkalon A/S Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Alkalon A/S Products Offered
11.14.5 Alkalon A/S Recent Development
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Corporation Information
11.15.2 Alliance Healthcare Description, Business Overview and Total Revenue
11.15.3 Alliance Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Alliance Healthcare Products Offered
11.15.5 Alliance Healthcare Recent Development
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Corporation Information
11.16.2 Allergan, Plc. Description, Business Overview and Total Revenue
11.16.3 Allergan, Plc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Allergan, Plc. Products Offered
11.16.5 Allergan, Plc. Recent Development
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Corporation Information
11.17.2 Reckitt Benckiser Plc. Description, Business Overview and Total Revenue
11.17.3 Reckitt Benckiser Plc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Reckitt Benckiser Plc. Products Offered
11.17.5 Reckitt Benckiser Plc. Recent Development
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Corporation Information
11.18.2 Bausch & Lomb Description, Business Overview and Total Revenue
11.18.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Bausch & Lomb Products Offered
11.18.5 Bausch & Lomb Recent Development
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Corporation Information
11.19.2 AbbVie Inc. Description, Business Overview and Total Revenue
11.19.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
11.19.4 AbbVie Inc. Products Offered
11.19.5 AbbVie Inc. Recent Development
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Corporation Information
11.20.2 The Colgate-Palmolive Company Description, Business Overview and Total Revenue
11.20.3 The Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
11.20.4 The Colgate-Palmolive Company Products Offered
11.20.5 The Colgate-Palmolive Company Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Projections by Region
12.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions 2021-2026
12.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions 2021-2026
12.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.2.1 North America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.2.2 North America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.2.3 North America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.3.1 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.3.2 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.3.3 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Region (2021-2026)
12.5 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.5.1 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.5.2 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.5.3 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Over the Counter (OTC) Drugs & Dietary Supplements Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
1.2 Market Segments
1.3 Key Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type
1.4.2 Analgesic & pain relievers
1.4.3 Dermatological products
1.4.4 Cough, cold, and flu products
1.4.5 Vitamin supplements
1.4.6 Mineral Supplements
1.4.7 Ophthalmic Products
1.5 Market by Application
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application
1.5.2 Pharmacies
1.5.3 Grocery Stores
1.5.4 Vitamin
1.5.5 Health Food Stores
1.5.6 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Over the Counter (OTC) Drugs & Dietary Supplements Industry Impact
1.6.1 How the Covid-19 is Affecting the Over the Counter (OTC) Drugs & Dietary Supplements Industry
1.6.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Over the Counter (OTC) Drugs & Dietary Supplements Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Over the Counter (OTC) Drugs & Dietary Supplements Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Estimates and Forecasts
2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2015-2026
2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026
2.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2020 Versus 2026
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OVER THE COUNTER (OTC) DRUGS & DIETARY SUPPLEMENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
3.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020)
3.1.2 Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers (2015-2020)
3.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers
3.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020)
3.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
3.2.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
3.4 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Base Distribution, Product Types
3.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
3.4.3 Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2015-2020)
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020)
4.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Type (2021-2026)
4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2015-2020)
5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020)
5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020)
5.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Application (2021-2026)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements by Country
6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
7 EUROPE
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements by Country
7.1.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
7.1.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements by Region
8.1.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region
8.1.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
8.3 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements by Country
9.1.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
9.1.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
9.3 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements by Country
10.1.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
10.1.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
10.3 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Corporation Information
11.2.2 Novartis International AG Description, Business Overview and Total Revenue
11.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.2.5 Novartis International AG Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Corporation Information
11.3.2 Roche Holding AG Description, Business Overview and Total Revenue
11.3.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.3.5 Roche Holding AG Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Corporation Information
11.4.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi S.A
11.5.1 Sanofi S.A Corporation Information
11.5.2 Sanofi S.A Description, Business Overview and Total Revenue
11.5.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.5.5 Sanofi S.A Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Corporation Information
11.7.2 Gilead Sciences Description, Business Overview and Total Revenue
11.7.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.7.5 Gilead Sciences Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Corporation Information
11.8.2 GlaxoSmithKline plc. Description, Business Overview and Total Revenue
11.8.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Corporation Information
11.9.2 Bayer Healthcare AG Description, Business Overview and Total Revenue
11.9.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.9.5 Bayer Healthcare AG Recent Development
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Corporation Information
11.10.2 AstraZeneca plc. Description, Business Overview and Total Revenue
11.10.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.10.5 AstraZeneca plc. Recent Development
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.1.5 Pfizer Inc. Recent Development
11.12 Alcon Inc.
11.12.1 Alcon Inc. Corporation Information
11.12.2 Alcon Inc. Description, Business Overview and Total Revenue
11.12.3 Alcon Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Alcon Inc. Products Offered
11.12.5 Alcon Inc. Recent Development
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Corporation Information
11.13.2 Alfresa Pharma Corporation Description, Business Overview and Total Revenue
11.13.3 Alfresa Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Alfresa Pharma Corporation Products Offered
11.13.5 Alfresa Pharma Corporation Recent Development
11.14 Alkalon A/S
11.14.1 Alkalon A/S Corporation Information
11.14.2 Alkalon A/S Description, Business Overview and Total Revenue
11.14.3 Alkalon A/S Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Alkalon A/S Products Offered
11.14.5 Alkalon A/S Recent Development
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Corporation Information
11.15.2 Alliance Healthcare Description, Business Overview and Total Revenue
11.15.3 Alliance Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Alliance Healthcare Products Offered
11.15.5 Alliance Healthcare Recent Development
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Corporation Information
11.16.2 Allergan, Plc. Description, Business Overview and Total Revenue
11.16.3 Allergan, Plc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Allergan, Plc. Products Offered
11.16.5 Allergan, Plc. Recent Development
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Corporation Information
11.17.2 Reckitt Benckiser Plc. Description, Business Overview and Total Revenue
11.17.3 Reckitt Benckiser Plc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Reckitt Benckiser Plc. Products Offered
11.17.5 Reckitt Benckiser Plc. Recent Development
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Corporation Information
11.18.2 Bausch & Lomb Description, Business Overview and Total Revenue
11.18.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Bausch & Lomb Products Offered
11.18.5 Bausch & Lomb Recent Development
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Corporation Information
11.19.2 AbbVie Inc. Description, Business Overview and Total Revenue
11.19.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
11.19.4 AbbVie Inc. Products Offered
11.19.5 AbbVie Inc. Recent Development
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Corporation Information
11.20.2 The Colgate-Palmolive Company Description, Business Overview and Total Revenue
11.20.3 The Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
11.20.4 The Colgate-Palmolive Company Products Offered
11.20.5 The Colgate-Palmolive Company Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Projections by Region
12.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions 2021-2026
12.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions 2021-2026
12.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.2.1 North America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.2.2 North America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.2.3 North America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.3.1 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.3.2 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.3.3 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Region (2021-2026)
12.5 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.5.1 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.5.2 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.5.3 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Over the Counter (OTC) Drugs & Dietary Supplements Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Segments
Table 2. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesic & pain relievers
Table 5. Major Manufacturers of Dermatological products
Table 6. Major Manufacturers of Cough, cold, and flu products
Table 7. Major Manufacturers of Vitamin supplements
Table 8. Major Manufacturers of Mineral Supplements
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. COVID-19 Impact Global Market: (Four Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Over the Counter (OTC) Drugs & Dietary Supplements Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Over the Counter (OTC) Drugs & Dietary Supplements Players to Combat Covid-19 Impact
Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application 2020-2026 (K MT)
Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Regions 2015-2020 (K MT)
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Regions (2015-2020)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020) (K MT)
Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturers (2015-2020)
Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
Table 24. Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Price (2015-2020) (USD/MT)
Table 27. Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 29. Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2015-2020)
Table 35. Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 42. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 43. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 44. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 45. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 47. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 48. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 50. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 51. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 52. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 53. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020) (K MT)
Table 55. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 59. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 61. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 62. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 63. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 66. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 67. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 68. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 69. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 75. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 77. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 78. Pfizer Inc. Corporation Information
Table 79. Pfizer Inc. Description and Major Businesses
Table 80. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Pfizer Inc. Product
Table 82. Pfizer Inc. Recent Development
Table 83. Novartis International AG Corporation Information
Table 84. Novartis International AG Description and Major Businesses
Table 85. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Novartis International AG Product
Table 87. Novartis International AG Recent Development
Table 88. Roche Holding AG Corporation Information
Table 89. Roche Holding AG Description and Major Businesses
Table 90. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Roche Holding AG Product
Table 92. Roche Holding AG Recent Development
Table 93. Merck & Co., Inc. Corporation Information
Table 94. Merck & Co., Inc. Description and Major Businesses
Table 95. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Merck & Co., Inc. Product
Table 97. Merck & Co., Inc. Recent Development
Table 98. Sanofi S.A Corporation Information
Table 99. Sanofi S.A Description and Major Businesses
Table 100. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Sanofi S.A Product
Table 102. Sanofi S.A Recent Development
Table 103. Johnson & Johnson Corporation Information
Table 104. Johnson & Johnson Description and Major Businesses
Table 105. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson Product
Table 107. Johnson & Johnson Recent Development
Table 108. Gilead Sciences Corporation Information
Table 109. Gilead Sciences Description and Major Businesses
Table 110. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Gilead Sciences Product
Table 112. Gilead Sciences Recent Development
Table 113. GlaxoSmithKline plc. Corporation Information
Table 114. GlaxoSmithKline plc. Description and Major Businesses
Table 115. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. GlaxoSmithKline plc. Product
Table 117. GlaxoSmithKline plc. Recent Development
Table 118. Bayer Healthcare AG Corporation Information
Table 119. Bayer Healthcare AG Description and Major Businesses
Table 120. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Bayer Healthcare AG Product
Table 122. Bayer Healthcare AG Recent Development
Table 123. AstraZeneca plc. Corporation Information
Table 124. AstraZeneca plc. Description and Major Businesses
Table 125. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. AstraZeneca plc. Product
Table 127. AstraZeneca plc. Recent Development
Table 128. Alacer Corp. Corporation Information
Table 129. Alacer Corp. Description and Major Businesses
Table 130. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 131. Alacer Corp. Product
Table 132. Alacer Corp. Recent Development
Table 133. Alcon Inc. Corporation Information
Table 134. Alcon Inc. Description and Major Businesses
Table 135. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Alcon Inc. Product
Table 137. Alcon Inc. Recent Development
Table 138. Alfresa Pharma Corporation Corporation Information
Table 139. Alfresa Pharma Corporation Description and Major Businesses
Table 140. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 141. Alfresa Pharma Corporation Product
Table 142. Alfresa Pharma Corporation Recent Development
Table 143. Alkalon A/S Corporation Information
Table 144. Alkalon A/S Description and Major Businesses
Table 145. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. Alkalon A/S Product
Table 147. Alkalon A/S Recent Development
Table 148. Alliance Healthcare Corporation Information
Table 149. Alliance Healthcare Description and Major Businesses
Table 150. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 151. Alliance Healthcare Product
Table 152. Alliance Healthcare Recent Development
Table 153. Allergan, Plc. Corporation Information
Table 154. Allergan, Plc. Description and Major Businesses
Table 155. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 156. Allergan, Plc. Product
Table 157. Allergan, Plc. Recent Development
Table 158. Reckitt Benckiser Plc. Corporation Information
Table 159. Reckitt Benckiser Plc. Description and Major Businesses
Table 160. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 161. Reckitt Benckiser Plc. Product
Table 162. Reckitt Benckiser Plc. Recent Development
Table 163. Bausch & Lomb Corporation Information
Table 164. Bausch & Lomb Description and Major Businesses
Table 165. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 166. Bausch & Lomb Product
Table 167. Bausch & Lomb Recent Development
Table 168. AbbVie Inc. Corporation Information
Table 169. AbbVie Inc. Description and Major Businesses
Table 170. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 171. AbbVie Inc. Product
Table 172. AbbVie Inc. Recent Development
Table 173. The Colgate-Palmolive Company Corporation Information
Table 174. The Colgate-Palmolive Company Description and Major Businesses
Table 175. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 176. The Colgate-Palmolive Company Product
Table 177. The Colgate-Palmolive Company Recent Development
Table 178. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions (2021-2026) (K MT)
Table 179. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Regions (2021-2026)
Table 180. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 181. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Regions (2021-2026)
Table 182. North America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 183. North America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 184. Europe: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 185. Europe: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Region (2021-2026) (K MT)
Table 187. Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Region (2021-2026) (US$ Million)
Table 188. Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 189. Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 190. Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 191. Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 193. Key Challenges
Table 194. Market Risks
Table 195. Main Points Interviewed from Key Over the Counter (OTC) Drugs & Dietary Supplements Players
Table 196. Over the Counter (OTC) Drugs & Dietary Supplements Customers List
Table 197. Over the Counter (OTC) Drugs & Dietary Supplements Distributors List
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Segments
Table 2. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesic & pain relievers
Table 5. Major Manufacturers of Dermatological products
Table 6. Major Manufacturers of Cough, cold, and flu products
Table 7. Major Manufacturers of Vitamin supplements
Table 8. Major Manufacturers of Mineral Supplements
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. COVID-19 Impact Global Market: (Four Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Over the Counter (OTC) Drugs & Dietary Supplements Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Over the Counter (OTC) Drugs & Dietary Supplements Players to Combat Covid-19 Impact
Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application 2020-2026 (K MT)
Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Regions 2015-2020 (K MT)
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Regions (2015-2020)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020) (K MT)
Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturers (2015-2020)
Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
Table 24. Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Price (2015-2020) (USD/MT)
Table 27. Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 29. Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2015-2020)
Table 35. Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 42. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 43. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 44. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 45. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 47. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 48. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 50. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 51. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 52. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 53. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020) (K MT)
Table 55. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 59. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 61. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 62. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 63. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 66. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 67. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 68. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 69. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 75. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 77. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 78. Pfizer Inc. Corporation Information
Table 79. Pfizer Inc. Description and Major Businesses
Table 80. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Pfizer Inc. Product
Table 82. Pfizer Inc. Recent Development
Table 83. Novartis International AG Corporation Information
Table 84. Novartis International AG Description and Major Businesses
Table 85. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Novartis International AG Product
Table 87. Novartis International AG Recent Development
Table 88. Roche Holding AG Corporation Information
Table 89. Roche Holding AG Description and Major Businesses
Table 90. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Roche Holding AG Product
Table 92. Roche Holding AG Recent Development
Table 93. Merck & Co., Inc. Corporation Information
Table 94. Merck & Co., Inc. Description and Major Businesses
Table 95. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Merck & Co., Inc. Product
Table 97. Merck & Co., Inc. Recent Development
Table 98. Sanofi S.A Corporation Information
Table 99. Sanofi S.A Description and Major Businesses
Table 100. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Sanofi S.A Product
Table 102. Sanofi S.A Recent Development
Table 103. Johnson & Johnson Corporation Information
Table 104. Johnson & Johnson Description and Major Businesses
Table 105. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson Product
Table 107. Johnson & Johnson Recent Development
Table 108. Gilead Sciences Corporation Information
Table 109. Gilead Sciences Description and Major Businesses
Table 110. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Gilead Sciences Product
Table 112. Gilead Sciences Recent Development
Table 113. GlaxoSmithKline plc. Corporation Information
Table 114. GlaxoSmithKline plc. Description and Major Businesses
Table 115. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. GlaxoSmithKline plc. Product
Table 117. GlaxoSmithKline plc. Recent Development
Table 118. Bayer Healthcare AG Corporation Information
Table 119. Bayer Healthcare AG Description and Major Businesses
Table 120. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Bayer Healthcare AG Product
Table 122. Bayer Healthcare AG Recent Development
Table 123. AstraZeneca plc. Corporation Information
Table 124. AstraZeneca plc. Description and Major Businesses
Table 125. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. AstraZeneca plc. Product
Table 127. AstraZeneca plc. Recent Development
Table 128. Alacer Corp. Corporation Information
Table 129. Alacer Corp. Description and Major Businesses
Table 130. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 131. Alacer Corp. Product
Table 132. Alacer Corp. Recent Development
Table 133. Alcon Inc. Corporation Information
Table 134. Alcon Inc. Description and Major Businesses
Table 135. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Alcon Inc. Product
Table 137. Alcon Inc. Recent Development
Table 138. Alfresa Pharma Corporation Corporation Information
Table 139. Alfresa Pharma Corporation Description and Major Businesses
Table 140. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 141. Alfresa Pharma Corporation Product
Table 142. Alfresa Pharma Corporation Recent Development
Table 143. Alkalon A/S Corporation Information
Table 144. Alkalon A/S Description and Major Businesses
Table 145. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. Alkalon A/S Product
Table 147. Alkalon A/S Recent Development
Table 148. Alliance Healthcare Corporation Information
Table 149. Alliance Healthcare Description and Major Businesses
Table 150. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 151. Alliance Healthcare Product
Table 152. Alliance Healthcare Recent Development
Table 153. Allergan, Plc. Corporation Information
Table 154. Allergan, Plc. Description and Major Businesses
Table 155. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 156. Allergan, Plc. Product
Table 157. Allergan, Plc. Recent Development
Table 158. Reckitt Benckiser Plc. Corporation Information
Table 159. Reckitt Benckiser Plc. Description and Major Businesses
Table 160. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 161. Reckitt Benckiser Plc. Product
Table 162. Reckitt Benckiser Plc. Recent Development
Table 163. Bausch & Lomb Corporation Information
Table 164. Bausch & Lomb Description and Major Businesses
Table 165. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 166. Bausch & Lomb Product
Table 167. Bausch & Lomb Recent Development
Table 168. AbbVie Inc. Corporation Information
Table 169. AbbVie Inc. Description and Major Businesses
Table 170. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 171. AbbVie Inc. Product
Table 172. AbbVie Inc. Recent Development
Table 173. The Colgate-Palmolive Company Corporation Information
Table 174. The Colgate-Palmolive Company Description and Major Businesses
Table 175. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 176. The Colgate-Palmolive Company Product
Table 177. The Colgate-Palmolive Company Recent Development
Table 178. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions (2021-2026) (K MT)
Table 179. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Regions (2021-2026)
Table 180. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 181. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Regions (2021-2026)
Table 182. North America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 183. North America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 184. Europe: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 185. Europe: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Region (2021-2026) (K MT)
Table 187. Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Region (2021-2026) (US$ Million)
Table 188. Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 189. Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 190. Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Country (2021-2026) (K MT)
Table 191. Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 193. Key Challenges
Table 194. Market Risks
Table 195. Main Points Interviewed from Key Over the Counter (OTC) Drugs & Dietary Supplements Players
Table 196. Over the Counter (OTC) Drugs & Dietary Supplements Customers List
Table 197. Over the Counter (OTC) Drugs & Dietary Supplements Distributors List
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Product Picture
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2020 & 2026
Figure 3. Analgesic & pain relievers Product Picture
Figure 4. Dermatological products Product Picture
Figure 5. Cough, cold, and flu products Product Picture
Figure 6. Vitamin supplements Product Picture
Figure 7. Mineral Supplements Product Picture
Figure 8. Ophthalmic Products Product Picture
Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2020 & 2026
Figure 10. Pharmacies
Figure 11. Grocery Stores
Figure 12. Vitamin
Figure 13. Health Food Stores
Figure 14. Online Pharmacies
Figure 15. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size 2015-2026 (US$ Million)
Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026 (K MT)
Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Figure 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region in 2019
Figure 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Figure 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region in 2019
Figure 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
Figure 25. Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Figure 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2015-2020)
Figure 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type in 2019
Figure 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Range (2015-2020)
Figure 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Figure 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2015-2020)
Figure 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application in 2019
Figure 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 39. U.S. Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.S. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 42. Canada Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 44. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 48. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 49. Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 60. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 61. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region in 2019
Figure 64. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region in 2019
Figure 65. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 66. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 72. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 88. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 89. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 92. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 93. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 100. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 101. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 102. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 105. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 106. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 108. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 110. U.A.E Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Product Picture
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2020 & 2026
Figure 3. Analgesic & pain relievers Product Picture
Figure 4. Dermatological products Product Picture
Figure 5. Cough, cold, and flu products Product Picture
Figure 6. Vitamin supplements Product Picture
Figure 7. Mineral Supplements Product Picture
Figure 8. Ophthalmic Products Product Picture
Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2020 & 2026
Figure 10. Pharmacies
Figure 11. Grocery Stores
Figure 12. Vitamin
Figure 13. Health Food Stores
Figure 14. Online Pharmacies
Figure 15. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size 2015-2026 (US$ Million)
Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026 (K MT)
Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Figure 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region in 2019
Figure 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Figure 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region in 2019
Figure 23. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
Figure 25. Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Figure 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2015-2020)
Figure 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type in 2019
Figure 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Range (2015-2020)
Figure 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Figure 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2015-2020)
Figure 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application in 2019
Figure 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 39. U.S. Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.S. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 42. Canada Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 44. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 48. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 49. Germany Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 60. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 61. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region in 2019
Figure 64. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region in 2019
Figure 65. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 66. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 72. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 88. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 89. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 92. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 93. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type in 2019
Figure 100. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2019
Figure 101. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate 2015-2020 (K MT)
Figure 102. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country in 2019
Figure 105. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 106. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 108. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2020) (K MT)
Figure 110. U.A.E Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate (2015-2020) (US$